RARE BIOTECH

WEBSITE UNDER CONSTRUCTION

Rare Biotech is targeting rare diseases and the development of orphan drugs.  

 

We identify, evaluate and develop technologies with therapeutic and commercial potential sourced from both academia and industry.  

 

Development plans are matched with appropriate sources of funding to accelerate the progression of technologies which reduces risk and provides attractive opportunities for future partners and investment.

 

Rare Biotech was founded in 2014 and is currently assembling initial technologies and funding.


Image description